Products

Published data show that i-FACTOR is not only cost-effective compared to autograft in ACDF, but is the dominant economic strategy.

OssDsign Catalyst is a synthetic bone graft that stimulates the formation of healthy bone tissue in spinal fusion surgeries.

The intra-articular single-injection viscosupplement is intended to treat knee osteoarthritis inTaiwan, through TCM Biotech International.

fiberFUSE Strip is formulated to enable optimized application for posterior cervical, posterior lumbar and degenerative spinal procedures.

The product can be molded to fill defects and supports an environment for bone growth via two formats: putty and strip.

The bone graft substitute was developed for a variety of procedures including lumbar spine, cervical spine and foot & ankle fusion.

Over 200 Fiber Anchors have been implanted during limited release. Usage doubled quarter over quarter, with repeat usage by multiple surgeons in more than a dozen locations.

Elute received authorization from FDA to use its EP Granules with Tobramycin in a pivotal clinical trial.

FDA requested data related to an application to begin a Phase I/II clinical trial for ORTHO-R as an adjunct to surgery in rotator cuff tear repair.

Orthocell was granted patents for its CelGro collagen rope in China and Hong Kong, bringing the number of countries in which it is patented to five.